[HTML][HTML] Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated …

R Kato, K Haratani, H Hayashi, K Sakai, H Sakai… - British journal of …, 2021 - nature.com
Abstract Background Cancer-associated fibroblasts (CAFs) in the tumour microenvironment
(TME) suppress antitumour immunity, and the tyrosine kinase inhibitor nintedanib has …

Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts.

R Kato, K Haratani, H Hayashi, K Sakai… - British Journal of …, 2020 - europepmc.org
Background Cancer-associated fibroblasts (CAFs) in the tumour microenvironment (TME)
suppress antitumour immunity, and the tyrosine kinase inhibitor nintedanib has antifibrotic …

Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts

R Kato, K Haratani, H Hayashi… - British journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Cancer-associated fibroblasts (CAFs) in the tumour microenvironment (TME)
suppress antitumour immunity, and the tyrosine kinase inhibitor nintedanib has antifibrotic …

Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts

R Kato, K Haratani, H Hayashi, K Sakai, H Sakai… - British Journal of …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Cancer-associated fibroblasts (CAFs) in the tumour microenvironment (TME) suppress …

[PDF][PDF] Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated …

R Kato, K Haratani, H Hayashi, K Sakai, H Sakai… - 2020 - med.kindai.ac.jp
BACKGROUND: Cancer-associated fibroblasts (CAFs) in the tumour microenvironment
(TME) suppress antitumour immunity, and the tyrosine kinase inhibitor nintedanib has …

[HTML][HTML] Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated …

R Kato, K Haratani, H Hayashi, K Sakai… - British Journal of …, 2021 - ncbi.nlm.nih.gov
Background Cancer-associated fibroblasts (CAFs) in the tumour microenvironment (TME)
suppress antitumour immunity, and the tyrosine kinase inhibitor nintedanib has antifibrotic …